Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wow these guys are good, leader board has changed to up 30% in 4 trading days.
"1. shawny816 $1,315,220.74 New York
2. cowboy777 $1,314,914.70 Texas
3. threebf $1,314,082.74 California
4. wantacar1 $1,314,082.74 Wisconsin
5. zoopy1820 $1,314,082.74 Illinois
6. BARTON $1,314,082.74 West Virginia
7. GOLDY999 $1,314,082.74 North Carolina
8. oslermed $1,314,082.74 Maryland
9. stephen got even $1,314,082.74 Florida
10. TxSteve $1,314,082.74 Texas"
Could be right, over 500million market cap rule, up 28% today.
The game is set-up unrealistically where you're trading the closing prices. I'm behind about 120k, probally cracked top 50000 :)
Anyone make it to top 50? I guess top 13 picked the same stock with max buying power :)
"1. BuyBuyBuster $1,228,043.68 Massachusetts
2. clarisaf $1,228,043.68 Florida
3. dlapin $1,228,043.68 Texas
4. docjrw $1,228,043.68 Illinois
5. Dowchaser $1,228,043.68 Florida
6. kssimmers $1,228,043.68 New York
7. Quincey Stock Pro $1,228,043.68 Colorado
8. roberttosti $1,228,043.68 New Jersey
9. sancudo83 $1,228,043.68 Florida
10. scotttt $1,228,043.68 New York
11. Sharpe1 $1,228,043.68 Connecticut
12. smileone $1,228,043.68 California
13. wmiller $1,228,043.68 Michigan
14. Jakobpop $1,226,825.16 Colorado
15. excoastie $1,226,043.68 Arkansas
16. finebokeh $1,226,043.68 Virginia
17. JimpalaN $1,226,043.68 Ohio
18. mmakled1 $1,226,043.68 Michigan
19. williamray $1,224,375.00 Washington"
Answer for todays bonus question is Washington Mutual. rumour of takeover target by citigroup.
Only stock I like from your list is GOOG :) ... rest just doesn't have enough beta. I think the winner will be a trader, you can't just buy/hold and hope to win I would think.
Thanks, yeah that was the correct answer.
Nah just sharing some info... it's only 2000 points per day. So what stocks you trading for the Maserati? I picked AAPL, SNDK so far a good call... I guess I'll do a scan and see which stock has the highest beta and pick few more.
Yeah, I'm playing it... whats the answer for todays bonus question? If I had to guess it's #3.
Since the 1950's whats the Dow's average move in month of April?
1) gain of 1.8%
2) gain of 2.3%
3) Loss of 0.6%
SNDK will probally move tomorrow in sympathy with FLSH who reports earnings before market opens. I expect FLSH to beat by 7-10cents 50-53cent vs 43 forcast but the spin on next quarter will be more important.
Jeff congrats on CELG, you picked a good time to swap into that from AAPL. Stock is a real monster after that upgrade.
Steve Jobs is on at 9am tomorrow pacific time at macworld, Earnings is on jan 18... kinda weak today.
Some dude on CNBC on friday or thursday put $2000 price target. Even Cramer has a $500 target price... history likes to repeat itself.
Nice...Lagging SNDK a bit now with that spurt to 77.
Isn't Prechter the guy who wrote "Crest at the tidal wave" ready for armageddon in the stock markets. I prefer Jimmy Rogers bearish view, at least he called the oil correctly when it was trading at 10.
Wow, they jammed up TTWO on that horrendous forcast... where is our buying opportunities with video gaming stocks when they wont let them drop.
Yeah, I liked the story and the stock split in feb, I thought there would be a bigger pull-back after the gap-up, but it's risen 8 points in last week... almost lock-step up move with SNDK point wise. I'll give my : bluehorse loves CELG stamp of approvable.
There is no way you can rank a money losing research company
I bet every single one of them would be a sell.
Looks like bluehorseshoe loves SNDK ready to test 52week high, up a bit more today.
Bluehorseshoe loves APPL... next stop 75.
I hate the new ticker...too much clutter.
I agree it's a total manipulation, It dropped 5 bucks on barrons article with a downgrade from DB who raised earnings estimate at the same time, then it does a slow drop of 10 in a day on old news about Intel entering the Nand flash market.
In november we had 3 barrons article repeating stuff we knew for years... like saifun, spansion, intel, hynix, etc... entering the market. Then they forget to mention Sandisk is not a manufacturer of flash memory... other then the joint venture they have with Toshiba. I guess apple lucked out they didn't make a joint venture with samsung.
So yeah there is manipulations, especially barrons writing article every 2-3 weeks on sandisk... I'm suprised they didn't write one this weekend with spansion spin off from AMD last friday.
So which stocks will benefit>? I missed the run-up on MEDI...
Looks like they are going to do a live flu-mist type of vaccine test.
"Sat Dec 17, 4:49 PM ET
WASHINGTON - In an isolation ward of a Baltimore hospital, up to 30 volunteers will participate in a bold experiment: A vaccine made with a live version of the most notorious bird flu will be sprayed into their noses.
ADVERTISEMENT
click here
First, scientists are dripping that vaccine into the tiny nostrils of mice. It doesn't appear harmful — researchers have weakened and genetically altered the virus so that no one should get sick or spread germs — and it protects the animals enough to try in people.
This is essentially FluMist for bird flu, and the hope is that, in the event of a flu pandemic, immunizing people through their noses could provide faster, more effective protection than the troublesome shots — made with a killed virus — the nation now is struggling to produce.
And if it works, this new vaccine frontier may not just protect against the bird flu strain, called H5N1, considered today's top health threat. It offers the potential for rapid, off-the-shelf protection against whatever novel variation of the constantly evolving influenza virus shows up next — through a library of live-virus nasal sprays that the
National Institutes of Health plans to freeze.
"It's high-risk, high-reward" research, said Dr. Brian Murphy, who heads the NIH laboratory where Dr. Kanta Subbarao is brewing the nasal sprays — including one for a different bird-flu strain that appeared safe during the first crucial human testing last summer.
"It might fail, but if it's successful, it might prevent hundreds of thousands of cases" of the next killer flu, Murphy said.
FluMist is the nation's nasal-spray vaccine that prevents regular winter flu. Developed largely through Murphy's lab, it's the only flu vaccine made with live but weakened influenza viruses.
The new project, a collaboration with FluMist manufacturer MedImmune Inc., piggybacks cutting-edge genetics technology onto that vaccine to create a line of FluMist-like sprays against different bird flus.
"That is a great, great idea," said Dr. John Treanor of the University of Rochester, among the flu specialists closely watching the project.
Regular winter flu shots are made with killed influenza viruses, and the government is stockpiling experimental bird-flu vaccine made the same way. But those bird-flu shots don't work as well as hoped. They require an incredibly high dose, delivered in two separate injections, to spark a protective immune response in people.
"In theory, a live-virus vaccine might actually work better. We don't know that because we've never tried one before," Treanor said.
Influenza is like a magician, constantly changing its clothes to avoid detection, thus making it difficult to develop effective vaccines.
Studding the virus' surface are two proteins called hemagglutinin — the H in H5N1 — and neuraminidase, the "N". They act as a wardrobe: There are 16 known hemagglutinin versions, and nine neuraminidases.
They're also what triggers the immune system to mount an attack, particularly hemagglutinin, the protein the body aims for when it makes flu-fighting antibodies.
When people catch the flu, they usually get H1 or H3 flu strains, which their bodies can recognize because variations have circulated among humans for decades.
Occasionally, genetically unique strains emerge. Until 1997, H5 strains had never been seen outside of birds. The virus essentially put on a coat that human immune systems didn't recognize. The result: Since 2003, a particularly strong H5N1 strain has infected more than 130 people in Asia, killing at least 70.
H9 and H7 strains also recently have jumped from birds to people, although so far they haven't been nearly as dangerous.
Researchers hope to create at least one live-virus nasal spray for each "H" subtype, a project costing about $16 million of the NIH's annual $67 million budget for flu vaccine research.
"The hemagglutinin is the major protective antigen, so that is what we're focusing on," explained Subbarao, a molecular geneticist who heads the project.
First on her list are the riskiest known bird flus: H5N1, with human tests planned for April. H9N2, which recently underwent the first round of human testing in an isolation ward at Johns Hopkins Bayview Medical Center. Then an H7 strain, followed by an H6 strain believed to share genes with the H5N1.
"By no means are we confident we're picking the right strain" to make first, because flu mutates so easily, Subbarao cautioned.
She chooses vaccine strains from those that U.S. scientists who are monitoring influenza in Asia cull from ducks, chickens and geese, and ship home for research.
Subbarao must customize those strains for safe vaccination: First, using a new technique called reverse genetics, she selects genes for bird-flu H and N antigens and removes genetic segments that make them dangerous. Then she adds the remaining gene segments to the regular weakened FluMist virus.
Stocks of the custom virus are grown in fertilized chicken eggs. Each is then carefully cracked by hand to drain out virus-loaded liquid that in turn is purified and put into a nasal spray.
In a high-security section of the lab, Subbarao dons a biohazard suit and exposes vaccinated mice to various bird flu strains.
Then it's time for human testing — in a hospital isolation ward just in case the weakened virus could infect someone.
It shouldn't, because "those problems don't exist in FluMist," said Murphy, citing studies of regular FluMist in day-care centers where youngsters routinely pass viruses back and forth.
Some studies have found that people can shed virus shortly after receiving regular FluMist. But, "to spread infection, you'd need much more (virus) than replicates in the nose," he said.
Hopkins researchers gave the first of Subbarao's vaccine candidates — the H9N2 spray — to 30 volunteers last summer. To be sure they couldn't spread the virus by coughing or sneezing, the volunteers underwent daily tests of their noses and throats.
The vaccine appeared safe. Scientists now are analyzing whether it also spurred production of flu-fighting antibodies, a sign that people would be protected if they encountered the H9N2 strain. Subbarao expects results by February.
In April, pending final
Food and Drug Administration permission, Subbarao will put an H5N1 spray to a similar test.
Here's the catch: Each flu strain has subtypes. An Indonesian version of H5N1, for example, was recently discovered that differs from a Vietnamese strain on which Subbarao's nasal spray — and the government's stockpiled shots — are based. She's now testing whether her vaccine protects mice against that new Indonesian strain.
If a novel flu strain begins spreading among people, how will Subbarao tell if her stored nasal vaccines are a good match to fight it?
NIH also will store blood samples from the people who test those sprays. Say a new H9 strain sparks an outbreak. That virus will be tested against those blood samples, and NIH could predict within a day which spray candidates work. If one does, the government could order doses manufactured from that frozen stock; if none do, scientists would have to try to brew a new vaccine.
How quickly doses could be manufactured is a different issue. All influenza vaccines, shots or spray, currently are brewed in chicken eggs, a time-consuming process that other research is seeking to improve.
"These are research projects," Murphy stresses — the nasal-spray concept could fail.
But he's optimistic. Live-virus vaccines, he maintains, are better immune stimulators."
I still think SNDK is a buy, although it was better value at 47 last week then today. Basically all 3 major players in this area are close to or making 52 week highs... LEXR, FLSH, SNDK being a lagger now.
I think the biggest earnings suprise in percentage term might be from FLSH, since the analyst hasn't upped the earnings estimates at all from last quarter when they beat by 6cents.
Thats true, I think my company used isopropyl alcohol for most cleaning but used distilled water to clean the ink area... but that was IBM machine and the ink was probally different from deskjet or bubble jet.
Well if the printer is expensive then by all means buy the cleaning kit :) ... but q-tip and water should be ok for the cheaper types.
I had the same problem recently with HP deskjet, clogged or dried ink at the cartridge area... I just wiped the cartridge with some damp toilet paper, water recommend not piss (salt bad).
Seriously printers are so cheap compared to the ink cartridges that it's almost disposable, it seems like a waste of money buying a cleaning kit... just use q-tip with water or alcohol to clean the area.
I'll second cleaning several times, and you might actually have to manually wipe down the ink jet area on the cartridge with some damp rag.
Well INET is down for me also.
Lets hope we get gap-down tomorrow then a ppt jam job to new highs. Looks like CAH broke 52week lows today next support is around 50. put a bid at 51.10 maybe hit it tomorrow.
Bought TASR at 43.45 probally will gap up as usual.
Don't sweat about Zeev's trades, I've scratched my head few times on some of his trades only because the window for that price was open for 5sec or less sometimes, so you're not going crazy.
Just enjoy zeev's forcast and his TA and FA analyst which is pretty good.
Yeah it was just a general question for anyone to answer. Search on yahoo is taking too long and the one that had a decent list hasn't been updated since 2002. Oh well probally only a front for someone doing program trading anyways.
http://www.allstocks.com/markets/Market_Makers/market_makers.html
I'm sure this has happened before but I didn't really notice it till today. Whats with all the crossed trade on level 2 with IMBA and PAIR. Who are these guys? . PAIR I've seen few times but never IMBA.
Actually I saw the bid go below 39 for a bit, not sure if it actually traded below 39 though... it's up at 41 now... and we still have CC to go. what a yoyo stock.
34 cents.. looks like beat by 2cents... all over the place AH )
Someone did a nice job shaking the tree today...
MM should show us who's the boss by closing all the market at exactly zero. market closed flat due to lack of sellers and buyers.
Lowered guidence... i see 39.60 now.
Intuit (INTU:Nasdaq - commentary - research) beat Wall Street's earnings expectations by four cents and posted record third quarter revenue, the tax software giant said after the closing bell Wednesday.
However, the company guidance for the fourth quarter was light on revenue, and included a bigger than expected loss.
If price manipulation is the complaint
For those companys giving option and those receiving its a win/win and only loser is the shareholder with dilution or company using earnings to keep the dilution minimal.
My biggest complaint with options is that it gets repriced for the executives if the stock is down and the option is underwater. So basically these guys make money when stock goes up and they make out ok when stock gets hammered... win/win for the people getting the option.
I should start a company or take over one and pay all employeses 30k cash but with 200k+ option bonus with a guaraantee (reprice) I bet i can make almost any company look good.
Democracy is fragile thing, don't let your feelings overcome your good sense, stop with the "negative ads" which is nothing more then verbal attacks. Before you know it, it'll turn physical and you'll have a civil war.
We should merge dem/rep and have 1 party, maybe the hate rhetoric based on party lines will disappear and we're only left with personal attacks.
Just curious do you guys vote the party line, because I never do, I've voted for rep/dem/independent/green and I think I registered as undecided or independent.
Kerry should win the election, Peace in Iraq is getting too messy for Bush. Kerry should pick a minority or female for VP, Hillary or maybe Jesse jackson.
Yeah just noticed KLAC is up 50cents also, some poster think ADI earnings is the reason. I guess they beat :)
NEW YORK, May 13 (Reuters) - Analog Devices Inc. (NYSE:ADI - News), a producer of microchips used in devices such as mobile phones, on Thursday said its fiscal second-quarter profit more than doubled driven by demand for chips for consumer electronics.
The Norwood, Mass.-based company said net income for the period ending May 1 rose to $152.6 million, or 39 cents a share, from $71.3 million, or 19 cents a share.
Analysts had forecast a profit of 35 cents a share, according to Reuters Research, a unit of Reuters Group Plc.
Yeah I got whipsawed, took position too soon thinking reversal day and when the 2:22 ramp looked like it might fail sold too soon. I really wish PPT would call me before they sit on the buy program button. Didn't think we would go green after the carnage though.
I guess today might be the pivot point and we change direction back to upside perhaps.
Probally thinly traded stock, or fast market when MM can get away with anything. I remember waiting 5min for confirmation on MACE when it traded thru my buy price 3 times+ 30cent on the low end and 30cent on the high end, and it took another 5min for the cancellation to go thru.
Well I guess we get the dump today, no decent up ticks yet for a chance of a reversal day. Doesn't look too good so far unless we get some buy program kick in and get some GPT to go along with todays GNT.
Since you covered, go long and ride the wave up. Setting up for reversal day but we could get melt down instead.
step ladder ramp job so far, we should hit the local high in the next hour and stay flat (tight trading range) till 2:20 when we will make new highs or take a hair cut.
The boyz and girlz did a nice job on the ramp, low volume and dow/sp laggard made lot of people question the validity.